{
  "id": "3aa0c60967e4d297",
  "title": "Libevitug approved in China as first - in - class treatment for hepatitis D",
  "description": "20260124T041500Z",
  "content": "",
  "source": "en.people.cn",
  "source_url": "http://en.people.cn/n3/2026/0124/c90000-20418265.html",
  "published_at": "20260124T041500Z",
  "fetched_at": "2026-01-25T00:26:39.131417+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "china"
  ],
  "location": "China",
  "raw_data": {
    "url": "http://en.people.cn/n3/2026/0124/c90000-20418265.html",
    "url_mobile": "",
    "title": "Libevitug approved in China as first - in - class treatment for hepatitis D",
    "seendate": "20260124T041500Z",
    "socialimage": "",
    "domain": "en.people.cn",
    "language": "English",
    "sourcecountry": "China"
  }
}